We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+7.94%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$20.8B
AUM Growth
+$401M
(+2%)
Cap. Flow
-$819M
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
34.88%
Holding
872
New
34
Increased
469
Reduced
316
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$311M |
| 2 |
Chevron
CVX
|
+$78M |
| 3 |
TSMC
TSM
|
+$55.6M |
| 4 |
Core Laboratories
CLB
|
+$42.1M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GG
Goldcorp Inc
GG
|
+$586M |
| 2 |
B
Barrick Mining
B
|
+$128M |
| 3 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$86.9M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$74.7M |
| 5 |
Kinross Gold
KGC
|
+$73.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 55.1% |
| 2 | Energy | 8.94% |
| 3 | Technology | 8.27% |
| 4 | Healthcare | 6.04% |
| 5 | Financials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Dow Inc
DOW
$20.8B
| $9.35M | 0.05% |
+189,593
| New | +$10M |
|
|
GRFS
227
Grifois
GRFS
$5.32B
| $9.27M | 0.04% |
439,375
-119,250
| -21% | -$2.27M |
|
228
Eaton
ETN
$152B
| $9.21M | 0.04% |
110,574
+10,214
| +10% | +$827K |
|
229
Ametek
AME
$54.8B
| $9.21M | 0.04% |
101,349
+785
| +0.8% | +$67.3K |
|
|
TWO
230
Two Harbors Investment
TWO
$1.27B
| $9.15M | 0.04% |
180,512
+31,573
| +21% | +$1.66M |
|
231
Tesla
TSLA
$1.21T
| $9.07M | 0.04% |
608,925
+168,585
| +38% | +$2.62M |
|
232
Bausch Health
BHC
$1.71B
| $9.02M | 0.04% |
357,815
+2,122
| +0.6% | +$50.4K |
|
|
CIM
233
Chimera Investment
CIM
$1.05B
| $9.01M | 0.04% |
159,182
+11,522
| +8% | +$653K |
|
234
MidCap Financial Investment
MFIC
$793M
| $8.97M | 0.04% |
568,064
+49,612
| +10% | +$780K |
|
235
AstraZeneca
AZN
$263B
| $8.88M | 0.04% |
107,583
-3,187
| -3% | -$250K |
|
|
IFFT
236
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
| $8.88M | 0.04% |
165,002
-6,344
| -4% | -$333K |
|
237
Blackstone Mortgage Trust
BXMT
$2.81B
| $8.87M | 0.04% |
249,189
+7,540
| +3% | +$268K |
|
238
AGCO
AGCO
$8.55B
| $8.82M | 0.04% |
113,731
-32,698
| -22% | -$2.33M |
|
239
Novartis
NVS
$297B
| $8.82M | 0.04% |
96,556
-19,149
| -17% | -$1.62M |
|
|
NE
240
DELISTED
Noble Corporation
NE
| $8.77M | 0.04% |
4,688,401
+1,586,351
| +51% | +$3.73M |
|
241
Sixth Street Specialty
TSLX
$1.63B
| $8.74M | 0.04% |
445,864
+65,868
| +17% | +$1.31M |
|
242
Neurocrine Biosciences
NBIX
$17.7B
| $8.64M | 0.04% |
102,283
-11,483
| -10% | -$943K |
|
|
AEPPL
243
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $8.62M | 0.04% |
161,001
-5,903
| -4% | -$309K |
|
244
Lowe's Companies
LOW
$119B
| $8.6M | 0.04% |
85,212
+859
| +1% | +$90.6K |
|
245
Sanofi
SNY
$106B
| $8.59M | 0.04% |
198,602
-16,389
| -8% | -$697K |
|
246
Viatris
VTRS
$20.4B
| $8.58M | 0.04% |
450,604
+135,749
| +43% | +$3M |
|
247
GSK
GSK
$105B
| $8.53M | 0.04% |
170,551
-14,795
| -8% | -$742K |
|
248
Johnson & Johnson
JNJ
$646B
| $8.45M | 0.04% |
60,640
-6,304
| -9% | -$873K |
|
249
Public Storage
PSA
$60.5B
| $8.41M | 0.04% |
35,323
+701
| +2% | +$161K |
|
|
NVO
250
Novo Nordisk
NVO
$219B
| $8.36M | 0.04% |
327,484
-51,330
| -14% | -$1.27M |
|
Similar funds
DAM
VanEck Associates's Q2 2019 Portfolio in Review
As of Q2 2019, VanEck Associates held 872 positions worth $20.8B, up 2% from $20.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
VanEck Associates withdrew a net $819M in Q2 2019, closing 42 positions and reducing 316 holdings. Its most notable exit was Goldcorp Inc, an estimated $586M position sold in full.
By sector, the portfolio is most concentrated in Materials at 55% of assets, down from 56% a quarter earlier, followed by Energy and Technology.
Against the trend, VanEck Associates opened a new position in Royal Dutch Shell PLC ADS Class B worth $38.4M.
- VanEck Associates's largest Q2 2019 buy was Royal Dutch Shell PLC ADS Class B: 584,700 shares worth $38.4M.
- VanEck Associates added most to Newmont in Q2 2019, an estimated $311M increase.
- VanEck Associates's biggest Q2 2019 reduction was Barrick Mining, cutting an estimated $128M.
- VanEck Associates fully exited Goldcorp Inc in Q2 2019, selling an estimated $586M.
- VanEck Associates's ten largest holdings make up 35% of its $20.8B portfolio in Q2 2019.
- VanEck Associates opened 34 new positions and closed 42 in Q2 2019.
- VanEck Associates's portfolio value rose 2% quarter-over-quarter to $20.8B.
Based on VanEck Associates's 13F filing for Q2 2019, filed 7 Aug 2019.